- Specializing in Creating Customized IVRs, Voice, SMS, Chat and HIPAA Compliant Secure Message Applications
Specializing in Creating Customized IVRs, Voice, SMS, Chat and HIPAA Compliant Secure Message Applications
Collecting patient-reported outcomes without breaking the blind
We are here to help
Healthcare Solutions
If you're in healthcare, you owe it to yourself to learn how you can make your everyday business processes more efficient and save money at the same time. We can help in automating many of your routine and repetitive tasks, including Patient Engagement surveys.
Contact us to learn more
Transportation Solutions
If you're in the transportation business, you can automate many of your routine tasks like package notifications, surveys, collection calls and more. Improve your customer satisfaction by extending your service hours without extending your costs.
Connect with us to learn more
How sponsors and sites can gather PROs, monitor safety, and preserve study integrity
Collecting patient-reported outcomes (PROs) and running safety monitoring in blinded clinical trials is an operational problem, not a scientific one. The technical and clinical teams often focus on assay schedules and imaging windows, while the day-to-day burden falls on coordinators who must keep per-participant timelines running. As sponsors approach interim analyses (ProMIS Neurosciences recently noted their PRECISE-AD Phase 1b trial nearing a blinded six-month look), the operational squeeze becomes familiar: get the right data from each participant on the right day, surface safety signals fast enough for clinical review, and do it without creating accidental unblinding.
That combination is trickier than it looks because every participant has their own timeline, not a single calendar schedule.
Where trials usually stumble
Three practical frictions show up repeatedly. First, per-person timelines. Each enrollee’s week-24 check-in is counted from their individual dosing date, so reminders, questionnaires, and alerts must follow that clock. Second, mixed channels. Participants prefer different ways to respond: phone calls, text messages, secure messaging, or in-clinic visits. Relying on a single channel leaves gaps. Third, safety triage. Certain answers need rapid clinical review. If those answers travel by the wrong channel, or land in an inbox nobody monitors, the trial risks slow reaction time or, worse, ad hoc manual work that leaks treatment clues.
These are operational problems that can be addressed without redesigning the trial. The goal is to preserve the blind while ensuring safety, completeness, and timeliness of PRO data.
What a working approach looks like in practice
Start from two simple principles: treat every participant as an independent timeline, and separate blinded data capture from clinical escalation. Practically, this means the systems that send reminders and collect PROs must know each participant’s scheduled check-in days, retry intelligently if initial contact fails, and record responses in a way that does not expose treatment assignment.
For safety monitoring, design a parallel path. Responses that meet predefined safety thresholds should trigger a protected alert that strips any trial-arm indicators. That alert goes to a clinical safety team or medical monitor who has a workflow to review items and decide whether unblinding is required. The point is to make the clinical decision upstream of any change in who sees treatment assignments.
A common operational pattern that works is a multi-channel capture mechanism with an escalation queue. Use voice or text messaging to reach participants who do not use smartphone apps. Keep an encrypted message store and an auditable trail so that when a site asks “did this participant answer their week-12 check-in?” the answer is straightforward. The archive should be readable by trial monitors without exposing allocation information.
Practical checklist for the next interim
- Confirm each participant's individual schedule is driving reminder timing, not a shared calendar.
- Define which PRO items should immediately alert clinical staff, and how those alerts are routed.
- Verify that data accessible to blinded reviewers contains only pooled results, while safety alerts use a separate, protected path.
Tradeoffs and where to be careful
There are honest tradeoffs. More frequent reminders increase response rates but can raise burden and fatigue. Adding voice calls will reach participants who ignore text messages, yet live calls create a higher operational cost. Escalation logic that is too sensitive will flood nurses with false positives, while logic that is too permissive risks missing genuine safety issues. The right balance depends on the protocol, the likely safety profile, and how busy the on-call clinical review team is.
Another common snag is data flow. Clinicians need structured answers they can act on without re-typing or manual reconciliation. That means the intake needs to land in the systems that clinical staff already use for triage, albeit in a blinded-safe form. It also means the team needs a tested process for handling exceptions, like missed visits or participants who change contact preference mid-study.
Finally, documentation matters. The system should produce an auditable record that can answer basic questions an auditor will ask, for example whether a scheduled PRO was attempted and what follow-up occurred. Keep that requirement simple and test it before the interim window opens.
The practical move is to plan the logistics early. In the weeks before a blinded interim analysis, sponsors should prioritize catch-up campaigns for outstanding PROs, validate escalation paths, and rehearse the flow of pooled safety summaries to the independent review committee. Those are the tasks that prevent last-minute data loss and that protect the blind.
For sponsors and sites considering how to add voice and text-message capture to a trial, there are practical designs that preserve blinding while improving completeness and safety monitoring. Review our services PRO collection.